Skip to content
Business
Link copied to clipboard

FMC Corp. sells unit for $200 million

FMC Corp. has reached an agreement to sell its peroxygens business for $200 million to One Equity Partners, an arm of J.P. Morgan Chase & Co.

JPMorgan Chase offices in Manhattan. FMC Corp. has reached an agreement to sell its peroxygens business for $200 million to One Equity Partners, an arm of J.P. Morgan Chase & Co.
JPMorgan Chase offices in Manhattan. FMC Corp. has reached an agreement to sell its peroxygens business for $200 million to One Equity Partners, an arm of J.P. Morgan Chase & Co.Read moreKATHY WILLENS / Associated Press
    Inquirer
    Published 

FMC Corp. has reached an agreement to sell its peroxygens business for $200 million to One Equity Partners, an arm of J.P. Morgan Chase & Co.

The deal is expected to close in early 2014 after regulatory reviews.

FMC, a Philadelphia chemical company, has said the business does not fit into its core product lines of crop protection, health and nutrition, alkali chemicals and lithium. - Bob Fernandez

    Inquirer